Healthcare -
Biotechnology - NASDAQ - US
$ 5.05
4.99 %
$ 54.5 M
Market Cap
-2.84
P/E
LTRN - TOTAL LIABILITIES & EQUITY
Total Liabilities & Equity LTRN - Lantern Pharma Inc.
43.6 M
LAST VALUE
-23.17%
2 YEAR CAGR
149.68%
5 YEAR CAGR
0.00%
10 YEAR CAGR